MicroTest Laboratories Release: New FDA Regulations Streamlining the Governance of Combination Products are Detailed in New White Paper
Published: Sep 10, 2013
AGAWAM, Mass.--(BUSINESS WIRE)--New Federal Food & Drug Administration (FDA) regulations have streamlined the governance of combination products — medical devices embedded with pharmaceutical or biologic components. A new white paper titled "Combination Products 3.0: Applying the New FDA Regulations in 2013" discusses the implications for manufacturers. The whitepaper is available to download at http://microtestlabs.com/combination-products-30.
Help employers find you! Check out all the jobs and post your resume.